Literature DB >> 21821316

Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.

Jessica B S Langbaum1, Kewei Chen, Lenore J Launer, Adam S Fleisher, Wendy Lee, Xiaofen Liu, Hillary D Protas, Stephanie A Reeder, Daniel Bandy, Meixiang Yu, Richard J Caselli, Eric M Reiman.   

Abstract

Epidemiological studies suggest that elevated blood pressure (BP) in midlife is associated with increased risk of Alzheimer's disease (AD) in late life. In this preliminary study, we investigated the extent to which BP measurements are related to positron emission tomography (PET) measurements of fibrillar amyloid-beta burden using Pittsburgh Compound-B (PiB) and fluorodeoxyglucose (FDG) PET measures of cerebral metabolic rate for glucose metabolism (CMRgl) in cognitively normal, late middle-aged to older adult apolipoprotein E (APOE) ε4 homozygotes, heterozygotes and noncarriers. PiB PET results revealed that systolic BP (SBP) and pulse pressure (PP) were each positively correlated with cerebral-to-cerebellar PiB distribution volume ratio (DVR) in frontal, temporal, and posterior-cingulate/precuneus regions, whereas no significant positive correlations were found between PiB distribution volume ratios and diastolic BP (DBP). FDG PET results revealed significant inverse correlations between each of the BP measures and lower glucose metabolism in frontal and temporal brain regions. These preliminary findings provide additional evidence that higher BP, likely a reflection of arterial stiffness, during late midlife may be associated with increased risk of presymptomatic AD. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821316      PMCID: PMC3236809          DOI: 10.1016/j.neurobiolaging.2011.06.020

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  61 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

Authors:  Z Guo; L Fratiglioni; M Viitanen; L Lannfelt; H Basun; J Fastbom; B Winblad
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

3.  15-year longitudinal study of blood pressure and dementia.

Authors:  I Skoog; B Lernfelt; S Landahl; B Palmertz; L A Andreasson; L Nilsson; G Persson; A Odén; A Svanborg
Journal:  Lancet       Date:  1996-04-27       Impact factor: 79.321

4.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

5.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

6.  Reducing the risk of dementia: efficacy of long-term treatment of hypertension.

Authors:  Rita Peila; Lon R White; Kamal Masaki; Helen Petrovitch; Lenore J Launer
Journal:  Stroke       Date:  2006-04-06       Impact factor: 7.914

7.  Cerebral blood flow in hypertensive patients: an initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks.

Authors:  J R Jennings; M F Muldoon; C M Ryan; M A Mintun; C C Meltzer; D W Townsend; K Sutton-Tyrrell; A P Shapiro; S B Manuck
Journal:  Hypertension       Date:  1998-06       Impact factor: 10.190

8.  Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project.

Authors:  Chengxuan Qiu; Eva von Strauss; Bengt Winblad; Laura Fratiglioni
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

9.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Authors:  Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  Lancet Neurol       Date:  2008-08-29       Impact factor: 44.182

10.  Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.

Authors:  Nien-Chen Li; Austin Lee; Rachel A Whitmer; Miia Kivipelto; Elizabeth Lawler; Lewis E Kazis; Benjamin Wolozin
Journal:  BMJ       Date:  2010-01-12
View more
  57 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Arterial stiffness and β-amyloid progression in nondemented elderly adults.

Authors:  Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Eric M McDade; William E Klunk; Ann D Cohen; Chester A Mathis; Steven T Dekosky; Julie C Price; Oscar L Lopez
Journal:  JAMA Neurol       Date:  2014-05       Impact factor: 18.302

3.  Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

Authors:  Sylvia Villeneuve; William J Jagust
Journal:  J Prev Alzheimers Dis       Date:  2015-03

4.  Excessive daytime sleepiness and fatigue may indicate accelerated brain aging in cognitively normal late middle-aged and older adults.

Authors:  Diego Z Carvalho; Erik K St Louis; Bradley F Boeve; Michelle M Mielke; Scott A Przybelski; David S Knopman; Mary M Machulda; Rosebud O Roberts; Yonas E Geda; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Sleep Med       Date:  2016-11-03       Impact factor: 3.492

Review 5.  Imaging the evolution and pathophysiology of Alzheimer disease.

Authors:  William Jagust
Journal:  Nat Rev Neurosci       Date:  2018-11       Impact factor: 34.870

6.  Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults.

Authors:  Daniel A Nation; Emily C Edmonds; Katherine J Bangen; Lisa Delano-Wood; Blake K Scanlon; S Duke Han; Steven D Edland; David P Salmon; Douglas R Galasko; Mark W Bondi
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

Review 7.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

8.  Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation.

Authors:  Anna E Blanken; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

9.  Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions.

Authors:  Christine M Burns; Kewei Chen; Alfred W Kaszniak; Wendy Lee; Gene E Alexander; Daniel Bandy; Adam S Fleisher; Richard J Caselli; Eric M Reiman
Journal:  Neurology       Date:  2013-03-27       Impact factor: 9.910

Review 10.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.